Ventum Cap Mkts Comments on Cresco Labs Q1 Earnings

Cresco Labs Inc. (OTCMKTS:CRLBF) – Research analysts at Ventum Cap Mkts issued their Q1 2025 earnings estimates for Cresco Labs in a research note issued on Wednesday, March 12th. Ventum Cap Mkts analyst A. Semple forecasts that the company will earn ($0.03) per share for the quarter. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Ventum Cap Mkts also issued estimates for Cresco Labs’ Q2 2025 earnings at ($0.03) EPS, Q3 2025 earnings at ($0.02) EPS and Q4 2025 earnings at ($0.02) EPS.

Separately, Atb Cap Markets downgraded shares of Cresco Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $3.00.

Cresco Labs Stock Performance

Shares of CRLBF stock opened at $0.75 on Friday. The company’s fifty day simple moving average is $0.89 and its 200-day simple moving average is $1.20. Cresco Labs has a 52 week low of $0.70 and a 52 week high of $2.60. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. The company has a market cap of $364.25 million, a PE ratio of -3.73 and a beta of 1.79.

Cresco Labs (OTCMKTS:CRLBF) last announced its quarterly earnings results on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01). Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. The company had revenue of $176.00 million for the quarter, compared to analyst estimates of $172.10 million.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.